Please login to the form below

Not currently logged in
Email:
Password:

Alexandre Lebeaut

This page shows the latest Alexandre Lebeaut news and features for those working in and with pharma, biotech and healthcare.

Ipsen’s liver cancer treatment clears phase III trial

Ipsen’s liver cancer treatment clears phase III trial

Cabometyx on track for new liver cancer indication

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Sotirios Stergiopoulos leaves Shire for Ipsen Dr Sotirios Stergiopoulos leaves Shire for Ipsen

    His new role will see him report to Alexandre Lebeaut, executive vice-president R&D and chief scientific officer of Ipsen, who said: “Stergiopoulos has extensive experience in directing global medical

  • Ipsen appoints executive vice president Ipsen appoints executive vice president

    Alexandre Lebeaut also set to be chief scientific officer. Ipsen has appointed Dr Alexandre Lebeaut as its new executive VP, research and development, and chief scientific officer to focus on the ... During his four years at Ipsen, Dr Lebeaut has been

  • Ipsen boosts specialty care and R&D leadership teams Ipsen boosts specialty care and R&D leadership teams

    Meanwhile, Dr Stergiopoulos (pictured left) has been appointed as senior vice president and head of global medical affairs, reporting to R&D lead Dr Alexandre Lebeaut. ... Dr Lebeaut said: “Sotirios brings extensive experience in directing global

  • Ipsen’s chief scientific officer steps down Ipsen’s chief scientific officer steps down

    Dr Claude Bertrand will be replaced ad interim by Alexandre Lebeaut. ... He will be replaced by Dr Alexandre Lebeaut as interim head of research and development while the firm searches for a permanent successor.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics